1,265 research outputs found
Análisis de Interacciones en Clases de Español de Primer Grado de Primaria
Este trabajo aborda la interacción profesor-alumnos en una clase de español en cuatro grupos escolares de primer grado de primaria de México, a partir de videos. Cada video fue segmentada en episodios interactivos que fueron analizados con categorías únicas estructuradas tanto para el maestro como para el alumno, según la taxonomía funcional de Ribes y López (1985): interacciones contextuales, suplementarias, selectoras, sustitutivas referenciales y sustitutivas no referenciales, y dos categorías de seguimiento didáctico. En general, en el primer grado se estructuran mayormente interacciones en el nivel funcional más sencillo, seguido por interacciones de instrucciones de seguimiento y realimentación. Asimismo, aunque en menor proporción, en dos de los cuatro grupos se presentaron interacciones en niveles funcionales más complejos
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer
The treatment of metastatic non-small cell lung cancer (NSCLC) has undergone a paradigm shift over the last decade. Better molecular characterization of the disease has led to the rapid improvement of personalized medicine and the prompt delivery of targeted therapies to patients with NSCLC. The discovery of the EML4-ALK fusion gene in a limited subset of patients affected by NSCLC and the subsequent clinical development of crizotinib in 2011 has been an impressive milestone in lung cancer research. Unfortunately, acquired resistances regularly develop, hence disease progression occurs. Afterward, modern tyrosine kinase inhibitors (TKIs), such as ceritinib, alectinib, brigatinib, and lorlatinib, have been approved by the Food and Drug Administration (FDA) for the management of anaplastic lymphoma kinase (ALK)-positive NSCLCs. Several compounds are currently under investigation to achieve the optimal strategy of therapy. Additionally, the results of ongoing clinical trials with novel-generation TKI will provide more evidence on the best sequence in the treatment of ALK-positive NSCLC patients. In this review, we provide a comprehensive overview of the state-of-the-art targeted therapy options in ALK-positive NSCLCs. Resistance, potential therapeutic strategies to overcome drug resistance, and future perspectives for this subset of patients are critically analyzed and summarized
Uses and Knowledge of Plant Species by Mongolian Herders in the Gobi Desert and Identification of Species of Interest for Planting
In Central Asia, many projects propose to establish single-species saxaul (Haloxylon ammodendron (C.A. Meyer) Bunge) plantations. An ethnobotanical survey was carried out among herders in Ulaanbadrakh, in the Dornogobi province, and herders in Gurvansaikhan, in the Dundgobi province in the Gobi Desert (Mongolia). The aim of this survey is to verify the interest of saxaul for the local populations, and to identify other woody species of interest for planting. Herders were questioned about the use of plant species from the Gobi grazing lands: livestock feed, human food, and then about plant species non-eaten by livestock and those that could be toxic to them. A total of 75 species and 413 uses related to these species were cited. We retained the species cited by at least 25% of the herders: 8 species of interest were selected, then sorted according to the number of associated positive uses, while focusing on the species cited in Ulaanbadrakh (area of interest in the Dornogobi). Saxaul appears to be the most numerous woody species for the herders and their livestock. Three other woody species of interest have also been identified. These results show that there is a high diversity of plant species used. It would be interesting to investigate the interest of a multi-species plantation for herders and their livestock in future surveys
Archaeogenetics and landscape dynamics in sicily during the holocene: A review
The Mediterranean islands and their population history are of considerable importance to the interpretation of the population history of Europe as a whole. In this context, Sicily, because of its geographic position, represents a bridge between Africa, the Near East, and Europe that led to the stratification of settlements and admixture events. The genetic analysis of extant and ancient human samples has tried to reconstruct the population dynamics associated with the cultural and demographic changes that took place during the prehistory and history of Sicily. In turn, genetic, demographic and cultural changes need to be understood in the context of the environmental changes that took place over the Holocene. Based on this framework, this paper aims to discuss the cultural and demographic dimension of the island by reviewing archaeogenetic studies, and lastly, we discuss the ecological constraints related to human peopling in times of change in landscapes that occurred on the island in various periods. Finally, possible directions for future archaeogenetic studies of Sicily are discussed. Despite its long human history, Sicily is still one of the world’s biodiversity hotspots. The lessons we learn from the past use of landscape provide models for sustainable future management of the Mediterranean’s landscapes
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
Background: The immune response in melanoma patients is locally affected by presence of tumor-infiltrating lymphocytes (TILs), generally divided into brisk, nonbrisk, and absent. Several studies have shown that a greater presence of TILs, especially brisk, in primary melanoma is associated with a better prognosis and higher survival rate. Patients and Methods: We investigated by enzyme-linked immunosorbent assay (ELISA) the correlation between PD-1 levels in plasma and the presence/absence of TILs in 28 patients with metastatic melanoma. Results: Low plasma PD-1 levels were correlated with brisk TILs in primary melanoma, whereas intermediate values correlated with the nonbrisk TILs, and high PD-1 levels with absent TILs. Although the low number of samples did not allow us to obtain a statistically significant correlation between the plasma PD-1 levels and the patients' overall survival depending on the absence/presence of TILs, the median survival of patients having brisk type TILs was 5 months higher than that of patients with absent and nonbrisk TILs. Conclusions: This work highlights the ability of measuring the plasma PD-1 levels in order to predict the prognosis of patients with untreated metastatic melanoma without a BRAF mutation at the time of diagnosis
First record of Temnosewellia minor (Platyhelminthes, Temnocephalidae) in Sicily, with a plea for a re-examination of the identity of the publicly available molecular sequences of the genus
Ectosymbiotic temnocephalan flatworms belonging to the genus Temnosewellia were collected on Cherax destructor in an aquaculture farm in Sicily, Italy. This represents the first record of a temnocephalan species for the fauna of the island. Morphological and molecular identification of the collected specimens proved that they belong to the allochthonous species Temnosewellia minor, which was introduced along with crayfishes bred in aquaculture farms. The phylogenetic analyses carried out for the molecular identification of the Sicilian population highlighted some inconsistencies in the grouping of the Temnosewellia sequences available online, thus stressing the opportunity of a careful re-examination of the voucher samples and their identifications. The risks of its unwary introduction in the wild and the need of monitoring its possible impacts on native biota are briefly discussed
The role of Aurora-A inhibitors in cancer therapy.
Recently, new chemotherapy agents which target the non-structural components of mitosis have been developed. An important protein involved in several mitotic phases is the Aurora-A protein. By means of the phosphorylation of different substrates, Aurora-A regulates the correct development of the various phases of mitosis. The kinase activity of this protein makes Aurora-A an excellent candidate as an oncogene. The first data of Aurora-A involvement in cancer regarded the identification of Aurora-A overexpression in primary breast and colon tumour samples. With regard to the predictive role of Aurora-A, it has been shown that its overexpression disrupts the spindle checkpoint activated by paclitaxel (Taxol) or nocodazole treatment, thus inducing the cells to become resistant to these drugs. The development therefore of small molecules with an Aurora-A inhibition function may make it possible to reduce or block the oncogenic activity of Aurora-A and in addition may improve the survival of oncological patients showing resistance to paclitaxel or nocodazole treatment. Three novel Aurora kinase inhibitors have recently been described--Hesperadin, ZM447439 and VX-680. All these three drugs have been designed to target the ATP-binding site of Aurora kinase, so they inhibit all three Aurora kinase family members showing a similar phenotype when tested in cell-based assays. Among these three different molecules, VX-680 has shown promising results in in vitro and in vivo studies. In conclusion, it is clear that we are entering a new era in anti-mitotic therapy with the identification and now clinical translation of new targets in mitosis beyond tubulin but many questions remain with regard to Aurora function
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER
Patterns of genomic instability in gastric cancer: clinical implications and perspectives
In gastric cancer (GC) the loss of genomic stability represents a key molecular step that occurs early in the carcinogenesis process and creates a permissive environment for the accumulation of genetic and epigenetic alterations in tumor suppressor genes and oncogenes. It is widely accepted that GC can follow at least two major genomic instability pathways, microsatellite instability (MSI) and chromosome instability (CIN). MSI is responsible for a well-defined subset of GCs. CIN represents a more common pathway comprising heterogeneous subsets of GC. In addition to MSI and CIN, the CpG islands methylator phenotype (CIMP) plays an important role in gastric carcinogenesis. CIMP may lead to the transcriptional silencing of various genes in gastric carcinogenesis. Intriguingly, more recently in addition to CpG island hypermethylation, a global DNA demethylation, that precedes genomic damage, has been observed in GC. Thus, epigenetic alterations may play a relevant role in gastric carcinogenesis as alternative mechanisms. Evidence suggests that although MSI, CIN and CIMP phenotypes can be distinguished from one another, there might be some degree of overlap. This review describes our current knowledge of the instability pathways in gastric carcinogenesis and the potential clinical applications for different forms of genomic instability in G
Hereditary ovarian cancer
Apoptosis is a form of cell death that permits the removal of damaged, senescent or unwanted cells in
multicellular organisms, without damage to the cellular microenvironment. Defective apoptosis represents
a major causative factor in the development and progression of cancer. The majority of chemotherapeutic
agents, as well as radiation, utilize the apoptotic pathway to induce cancer cell death. Resistance to standard
chemotherapeutic strategies also seems to be due to alterations in the apoptotic pathway of cancer cells.
Recent knowledge on apoptosis has provided the basis for novel targeted therapies that exploit apoptosis to
treat cancer. These new target include those acting in the extrinsic/intrinsic pathway, proteins that control the
apoptosis machinery such as the p53 and proteosome pathway. Most of these forms of therapy are still in
preclinical development because of their low specifity and susceptibility to drug resistance, but several of them
have shown promising results. In particular, this review specifically aims at providing an update of certain
molecular players that are already in use in order to target apoptosis (such as bortezomib) or which are still being
clinically evaluated (such ONYX-015, survivin and exisulind/aptosyn) or which, following preclinical studies,
might have the necessary requirements for becoming part of the anticancer drug programs (such as TRAIL/
Apo2L, apoptin/VP3).
Key words: apoptosis, TRAIL/Apo2L, apoptin/VP3, ONYX015, Bortezomib, exisulind, survivi
- …